Clinical Trials
7 trialsNCT05549232 2025-07-23
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
Hemanext
Completed
NCT01924689 2019-09-09
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Phase 1 Completed
NCT00743379 2015-05-07
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
Threshold Pharmaceuticals
Phase 1/2 Completed
NCT01075399 2013-08-30
HX4-200
Siemens Molecular Imaging
Phase 2 Completed
NCT01213030 2012-09-25
Clinical Evaluation of the New Hypoxia Imaging Agent HX4
Siemens Molecular Imaging
Phase 1/2 Completed
NCT00495144 2012-07-27
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
Threshold Pharmaceuticals
Phase 1 Completed
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed